269 related articles for article (PubMed ID: 25761648)
1. Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapy.
Mu Q; Jeon M; Hsiao MH; Patton VK; Wang K; Press OW; Zhang M
Adv Healthc Mater; 2015 Jun; 4(8):1236-45. PubMed ID: 25761648
[TBL] [Abstract][Full Text] [Related]
2. Time-Resolved MRI Assessment of Convection-Enhanced Delivery by Targeted and Nontargeted Nanoparticles in a Human Glioblastoma Mouse Model.
Stephen ZR; Chiarelli PA; Revia RA; Wang K; Kievit F; Dayringer C; Jeon M; Ellenbogen R; Zhang M
Cancer Res; 2019 Sep; 79(18):4776-4786. PubMed ID: 31331912
[TBL] [Abstract][Full Text] [Related]
3. Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway.
Chen H; Wen J
Eur J Pharmacol; 2022 Apr; 921():174860. PubMed ID: 35278406
[TBL] [Abstract][Full Text] [Related]
4. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
[TBL] [Abstract][Full Text] [Related]
5. Magnetic targeting of paclitaxel-loaded poly(lactic-
Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
[TBL] [Abstract][Full Text] [Related]
6. Hexanoyl-Chitosan-PEG Copolymer Coated Iron Oxide Nanoparticles for Hydrophobic Drug Delivery.
Hsiao MH; Mu Q; Stephen ZR; Fang C; Zhang M
ACS Macro Lett; 2015 Apr; 4(4):403-407. PubMed ID: 26900510
[TBL] [Abstract][Full Text] [Related]
7. Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo.
Deng W; Qiu J; Wang S; Yuan Z; Jia Y; Tan H; Lu J; Zheng R
Int J Nanomedicine; 2018; 13():439-453. PubMed ID: 29403275
[TBL] [Abstract][Full Text] [Related]
8. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
[TBL] [Abstract][Full Text] [Related]
9. Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy.
Agarwal S; Mohamed MS; Mizuki T; Maekawa T; Sakthi Kumar D
J Mater Chem B; 2019 Oct; 7(39):5896-5919. PubMed ID: 31423502
[TBL] [Abstract][Full Text] [Related]
10. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L
Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068
[TBL] [Abstract][Full Text] [Related]
11. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
12. Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma.
Ruan C; Liu L; Lu Y; Zhang Y; He X; Chen X; Zhang Y; Chen Q; Guo Q; Sun T; Jiang C
Acta Pharm Sin B; 2018 Jan; 8(1):85-96. PubMed ID: 29872625
[TBL] [Abstract][Full Text] [Related]
13. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
14. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
Gu G; Xia H; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Chen H; Gao X; Chen J
Biomaterials; 2013 Jan; 34(1):196-208. PubMed ID: 23069707
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide nanoparticles for targeted glioblastoma therapy.
Fang C; Wang K; Stephen ZR; Mu Q; Kievit FM; Chiu DT; Press OW; Zhang M
ACS Appl Mater Interfaces; 2015 Apr; 7(12):6674-82. PubMed ID: 25751368
[TBL] [Abstract][Full Text] [Related]
16. Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells.
Mu Q; Kievit FM; Kant RJ; Lin G; Jeon M; Zhang M
Nanoscale; 2015 Nov; 7(43):18010-4. PubMed ID: 26469772
[TBL] [Abstract][Full Text] [Related]
17. PEI-Coated Fe₃O₄ Nanoparticles Enable Efficient Delivery of Therapeutic siRNA Targeting REST into Glioblastoma Cells.
Wang R; Degirmenci V; Xin H; Li Y; Wang L; Chen J; Hu X; Zhang D
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065155
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
19. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
[TBL] [Abstract][Full Text] [Related]
20. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
